Shanghai Haohai Biological Technology Co., Ltd. (688366/06826) announced that on December 11, 2025, the company repurchased 51,000 shares for a total of HK$1.36 million.
According to the share repurchase authorization resolution, the company is permitted to repurchase up to 3.91 million shares in total. So far, it has repurchased 2.34 million shares, accounting for 5.9859% of the total issued shares at the time the resolution was passed.
In the first three quarters of 2025, Shanghai Haohai Biological Technology reported revenue of RMB 1.899 billion and net profit attributable to shareholders of RMB 305 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments